Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
2
self-reported 2–10 band
Founded
2024
2 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
CONTORAL HEALTH PTE. LTD.Entity record →
UEN202445273H
Legal entities
Show as table · Contoral Health Pte Ltd: 1 registry entity
| CONTORAL HEALTH PTE. LTD. | UEN 202445273H |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Continuous oral delivery represents a groundbreaking advancement in drug delivery. Currently, continuous drug delivery is typically limited to invasive pumps, subcutaneous devices, and buccal patches. The Contoral device introduces a novel method by providing continuous delivery directly in the mouth.
Contoral's first device targets Xerostomia, or Dry Mouth, a common side effect of cancer therapies that can lead to swallowing and sleep difficulties, as well as a decline in oral health. Existing treatments like gels, rinses, and sprays wear off quickly.
The device is a small, disposable cartridge pre-filled with an oral gel, powered by a spring-loaded syringe that releases the gel slowly through a small opening. The cartridge is held in place by a custom oral appliance, similar to a dental retainer. The device can be worn anytime but is most convenient overnight, as it must be removed while eating. The gel contains active enzymes, including xylitol, which stimulate the salivary glands.
To obtain the Contoral device, patients will visit a dentist in order to have a custom-made appliance. The device can also be attached to other oral appliances such as dentures, false teeth/crowns, or dental bites.
The Contoral device is currently under development. In the future, Contoral plans to expand its technology to treat conditions such as Parkinson’s Disease, and eventually explore other areas like neurology and pain management.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG11 Mandalay Road; 16-01; Novena, Central 308232Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Contoral Health Pte Ltd?
One Singapore entity on ACRA: CONTORAL HEALTH PTE. LTD. (UEN 202445273H), high confidence.
How many people work at Contoral Health Pte Ltd?
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Contoral Health Pte Ltd have offices?
One address on record, Singapore only. Primary: 11 Mandalay Road, 16-01, Novena, Central 308232.
Has Contoral Health Pte Ltd raised funding?
None linked to this brand.
Which companies are listed alongside Contoral Health Pte Ltd?
5 profiles list Contoral Health Pte Ltd as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. Trisafe Biotech Pte Ltd and RNAscence Biotechnology list it back.